CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Sesen Bio

For profitWebsite ↗

Also known as: Eleven Biotherapeutics

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Nov 1, 2012

Last known activity

Sep 1, 2016

Acquired by Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics → Sesen Bio → Carisma Therapeutics on Oct 9, 2022

Timeline

2010s

  1. Jun 1, 2010

    Sesen Bio— Founded

  2. Jun 1, 2016

    Viventia— Acquired

  3. Sep 21, 2016

    Viventia Biotech Inc.— Acquired

2020s

  1. Sep 21, 2022

    Carisma Therapeutics— Acquired

  2. Oct 9, 2022

    Carisma Therapeutics— Acquired By

  3. Oct 9, 2022

    Carisma Therapeutics— Now

Drugs by trial phase (6 distinct, 14 trials)

Phase 3 (0 own, 2 via acquisition)

Phase 1 (0 own, 4 via acquisition)

Indications

Studied for

Subsidiaries (3 direct, 51 total across the full acquisition tree)

Recent trials (13)

Details

Founded
Cambridge, MA, US Jun 1, 2010
Last known activity
Sep 1, 2016